Zobrazeno 1 - 10
of 23
pro vyhledávání: '"Claire, Patterson"'
Autor:
Parmesh Gajjar, Jake Dickinson, Harri Dickinson, Linette Ruston, Hitesh B Mistry, Claire Patterson, Paul A Dickinson
Publikováno v:
British Journal of Pharmacy, Vol 7, Iss 2 (2022)
Demonstrating bioequivalence (BE) is important for the development of lower-cost generic products, and also for approving post-submission manufacturing changes. However, for many complex parenteral products, BE demonstration can be very challenging.
Externí odkaz:
https://doaj.org/article/c0cbd0c6968b4276bb1ea30e5eb83198
Publikováno v:
Frontiers in Marine Science, Vol 7 (2020)
Concern about the effects of maritime vessel collisions with marine animals is increasing worldwide. To date, most scientific publications on this topic have focused on the collisions between large vessels and large whales. However, our review found
Externí odkaz:
https://doaj.org/article/430622ac355847c0a4dc2ecf10d3d228
Autor:
Samual T. Williams, Wendy Collinson, Claire Patterson-Abrolat, David G. Marneweck, Lourens H. Swanepoel
Publikováno v:
PeerJ, Vol 7, p e6650 (2019)
As the global road network expands, roads pose an emerging threat to wildlife populations. One way in which roads can affect wildlife is wildlife-vehicle collisions, which can be a significant cause of mortality through roadkill. In order to successf
Externí odkaz:
https://doaj.org/article/a7ccc55d89f342f89ad92429a7ff92f3
Autor:
Parmesh Gajjar, Jake Dickinson, Harri Dickinson, Linette Ruston, Hitesh B. Mistry, Claire Patterson, Paul A. Dickinson
Publikováno v:
Gajjar, P, Dickinson, J, Dickinson, H, Ruston, L, Mistry, H B, Patterson, C & Dickinson, P A 2022, ' Determining bioequivalence possibilities of long acting injectables through population PK modelling ', European Journal of Pharmaceutical Sciences, vol. 179, pp. 106296 . https://doi.org/10.1016/j.ejps.2022.106296
Long acting injectables (LAI) products are a popular intervention for treating a number of chronic conditions,with their long drug release reducing the administration frequency and thus improving patient adherence.The extended release, however, can p
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::215bae9bda3603ee7c158672ee47c0ab
https://doi.org/10.1016/j.ejps.2022.106296
https://doi.org/10.1016/j.ejps.2022.106296
Autor:
Nadim Akhtar, Marianne B. Ashford, Louisa Beer, Alex Bowes, Tony Bristow, Anders Broo, David Buttar, Steve Coombes, Rebecca Cross, Emma Eriksson, Jean-Baptiste Guilbaud, Stephen W. Holman, Leslie P. Hughes, Mark Jackman, M. Jayne Lawrence, Jessica Lee, Weimin Li, Rebecca Linke, Najet Mahmoudi, Marc McCormick, Bryce MacMillan, Ben Newling, Maryann Ngeny, Claire Patterson, Andy Poulton, Andrew Ray, Natalie Sanderson, Silvia Sonzini, Yayan Tang, Kevin E. Treacher, Dave Whittaker, Stephen Wren
Publikováno v:
Journal of pharmaceutical sciences.
The recent emergence of drug-dendrimer conjugates within pharmaceutical industry research and development introduces a range of challenges for analytical and measurement science. These molecules are very high molecular weight (100-200kDa) with a sign
Autor:
Alex Mattinson, David Lindley, Helena Engman, Manthena V.S. Varma, Anh-Thu Nguyen-Trung, Binfeng Xia, Xavier Pepin, Linette Ruston, Wei Zhu, Bill van Osdol, Celine Ollier, David Good, Jonathan Brown, Laurent Boulu, Talia Flanagan, Olivier Nicolas, Staffan Berg, Shanoo Budhdeo, Aarti Patel, Jan Bevernage, Handan He, Sweta Modi, Richard Barker, Claire Jackson, Christer Tannergren, Xiojun Ren, Stephane Beilles, J. Matthew Wood, Johanna Laru, Pierre Daublain, Sara Carlert, Louis Henrion, Jean-Flaubert Nguefack, Gunilla Hanisch, Eva Karlsson, Wen Lin, Shruthi Vaidhyanathan, Robert Carr, Fan Wu, Jin Zhang, Amais Ahmad, James M. Mullin, Sari Pappinen, Andrea Moir, Ke Szeto, Christine Xu, Claire Patterson, David B. Turner, Guillaume Louit, Yuya Wang, Tycho Heimbach, Richard Lloyd, Frans Franek, Masoud Jamei, Christophe Tistaert, Bertil Abrahamsson, Kerstin Julia Schäfer, Leon Aarons, Shriram M. Pathak, Adam S. Darwich, Suet Wong, Dónal Murphy, Amin Rostami-Hodjegan, Timo Korjamo, Helena Thörn, Kartrin Schmid, Michael B. Bolger, Johanna Tuunainen, Mai Anh Nguyen
Publikováno v:
European Journal of Pharmaceutics and Biopharmaceutics. 156:50-63
Oral drug absorption is a complex process depending on many factors, including the physicochemical properties of the drug, formulation characteristics and their interplay with gastrointestinal physiology and biology. Physiological-based pharmacokinet
Autor:
Silvia Sonzini, Fanny Caputo, Dora Mehn, Luigi Calzolai, Sven Even Borgos, Astrid Hyldbakk, Kevin Treacher, Weimin Li, Mark Jackman, Najet Mahmoudi, M. Jayne Lawrence, Claire Patterson, David Owen, Marianne Ashford, Nadim Akhtar
Publikováno v:
International Journal of Pharmaceutics. 637:122905
Publikováno v:
Trigeminal Neuralgia and Other Cranial Neuralgias ISBN: 0198871600
The Trigeminal Neuralgia Association (now the Facial Pain Association) was formed in 1990 in the USA. A network of similar support groups exists around the world to educate both professionals and patients, raise awareness, and allow patients with tri
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::775fb6ff8f2fada1c165c026a110eaee
https://doi.org/10.1093/med/9780198871606.003.0017
https://doi.org/10.1093/med/9780198871606.003.0017
Autor:
Ammar Adam, David J. Owen, Justin Cidado, Claire Patterson, Matthew Skinner, Stuart Purbrick, Lorraine Graham, Petar Pop-Damkov, Michael Giannis, Srividya B. Balachander, Francis D. Gibbons, William McCoull, Marianne Ashford, Hill Kathryn Jane, Martin Wild, Eric Gangl, Stephen Fawell, Corinne Reimer, Sean Redmond, Paul D. Kemmitt, Barry R. Davies, Jamal Carlos Saeh, Shenghua Wen, J. Paul Secrist, Alwin Schuller, Edward J. Hennessy, Sonya Gales, Iain Grant, Alexander R. Harmer, Jeremy S. Parker, Brian Kelly
Publikováno v:
Communications Biology
Communications Biology, Vol 4, Iss 1, Pp 1-14 (2021)
Communications Biology, Vol 4, Iss 1, Pp 1-14 (2021)
Dual Bcl-2/Bcl-xL inhibitors are expected to deliver therapeutic benefit in many haematological and solid malignancies, however, their use is limited by tolerability issues. AZD4320, a potent dual Bcl-2/Bcl-xL inhibitor, has shown good efficacy howev
Publikováno v:
Pharmaceutical Research
Purpose Subcutaneously or intramuscularly administered biodegradable microsphere formulations have been successfully exploited in the management of chronic conditions for over two decades, yet mechanistic understanding of the impact of formulation at